| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 10/02/2002 | EP1244452A1 Urotensin-ii receptor antagonists |
| 10/02/2002 | EP1244451A1 Substituted piperazine and piperidine calcium channel blockers |
| 10/02/2002 | EP1244450A1 8-aza-bicyclo[3.2.1]octane nmda/nr2b antagonists |
| 10/02/2002 | EP1244447A2 Novel methods and compositions involving opioids and antagonists thereof |
| 10/02/2002 | EP1244443A1 Method for increasing the concentration of ascorbic acid in brain tissues of a subject |
| 10/02/2002 | EP1244441A1 Use of trimebutine for treating pain |
| 10/02/2002 | EP1244440A1 Agonists specific for the peripheral cannabinoid receptor |
| 10/02/2002 | EP1244437A1 Tertiary amino compounds having opioid receptor affinity |
| 10/02/2002 | EP1244435A2 POLYHYDROXYLATED AROMATIC COMPOUNDS FOR THE TREATMENT OF AMYLOIDOSIS AND $g(a)-SYNUCLEIN FIBRIL DISEASES |
| 10/02/2002 | EP1244431A1 Transdermal administration of reboxetine |
| 10/02/2002 | EP1244356A1 Compositions and methods for l-nucleosides, l-nucleotides, and their analogs |
| 10/02/2002 | EP1129091B1 Crf receptor antagonists and methods relating thereto |
| 10/02/2002 | EP1100803B1 Pyrrolo [2,1-b] [1,3]benzothiazepines with atypical antipsychotic activity |
| 10/02/2002 | EP1098894B1 Fkbp inhibitors |
| 10/02/2002 | EP1047684B1 Substituted alpha,beta-anellated butyrolactones |
| 10/02/2002 | EP1007062A4 Therapeutic use of hemoglobin to treat head injury |
| 10/02/2002 | EP0984787B1 Use of low-molecular-weight heparins for preventing and treating cerebral edemas |
| 10/02/2002 | EP0906301B1 Benzofuryl derivatives and their use |
| 10/02/2002 | EP0843675B1 Aza-anthracyclinone derivatives |
| 10/02/2002 | EP0804196B1 Use of serotonin antagonists (5ht 3) for treating fibromyalgia |
| 10/02/2002 | EP0689534B1 Amide derivatives as 5-ht 1a? ligands |
| 10/02/2002 | DE10114138A1 Cdk-inhibitorische Indirubinderivate mit erhöhter Löslichkeit Cdk-inhibitory indirubin derivatives with increased solubility |
| 10/02/2002 | DE10113513A1 Drug combination of kinase inhibitor and neurotropic factor, useful for treating and/or preventing nerve and/or glial cell damage, e.g. associated with neurodegenerative diseases |
| 10/02/2002 | DE10112825A1 HESylierung von Wirkstoffen in wässriger Lösung HESylation of drugs in aqueous solution |
| 10/02/2002 | DE10111486A1 Verwendung einer oder mehrerer neuroaktiver Substanzen zur Behandlung der Parkinsonschen Krankheit Using one or more of neuroactive substances for the treatment of Parkinson's disease |
| 10/02/2002 | DE10108122A1 Arzneimittel auf Basis von Tramadol Medicines based on tramadol |
| 10/02/2002 | CN1372594A OX2 receptor homologs |
| 10/02/2002 | CN1372569A Keratinocyte growth factor-2 |
| 10/02/2002 | CN1372563A Oxathiepino [6,5-b] dihydropyridines, and related compositions and methods |
| 10/02/2002 | CN1372557A Neurotrophin production/secretion promoting agent |
| 10/02/2002 | CN1372555A Compositions and therapeutic mehtods involving isoflavones and analogues thereof |
| 10/02/2002 | CN1372547A Aminoalkoxy carbazoles for the treatment of CNS diseases |
| 10/02/2002 | CN1372546A Fused pyrrolecarboxamides GABA brain receptor ligands |
| 10/02/2002 | CN1372545A 吲哚衍生物 Indole derivatives |
| 10/02/2002 | CN1372544A 新颖的维生素d类似物 Novel analogues of vitamin d |
| 10/02/2002 | CN1372543A new vitamin derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments |
| 10/02/2002 | CN1372474A Methods for preventing or attenuating patthoangiogenic conditions |
| 10/02/2002 | CN1372473A Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
| 10/02/2002 | CN1371903A Optical isomer of 3-methyl fentanyl, derivant, synthesizing and its analgesic activity |
| 10/02/2002 | CN1371732A Beverage for relieving alcoholism |
| 10/02/2002 | CN1371686A Indomeizine external ointment for anti-inflammatory and stopping pain |
| 10/02/2002 | CN1091769C mesylate dihydrate salts of 5-(2-(4-(1,2-benzi sothiazol-2-yl)-1-piperazinyl)-ethyl)-6-chloro-1, 3-dihydro-2(1H)-indol-2-one |
| 10/02/2002 | CN1091768C Novel benzo-1,3-dioxolyl-and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists |
| 10/02/2002 | CN1091598C Pharmaceutical use of benzothiophene |
| 10/01/2002 | US6459003 Ether compounds |
| 10/01/2002 | US6458973 Process for the preparation of 5-carboxyphthalide |
| 10/01/2002 | US6458951 For treatment of male erectile dysfunction, female sexual dysfunction |
| 10/01/2002 | US6458846 Ion channel modulating agents |
| 10/01/2002 | US6458840 Use of valproic acid analog for the treatment and prevention of migraine and affective illness |
| 10/01/2002 | US6458837 Lipophilic diesters of chelating agents |
| 10/01/2002 | US6458830 The compounds are of particular use in the treatment or prevention of depression, anxiety, pain, inflammation, migraine, emesis and postherpetic neuralgia. |
| 10/01/2002 | US6458829 Substituted γ-phenyl-Δ-lactones and analogs thereof and uses related thereto |
| 10/01/2002 | US6458827 Adjustent of conformation equilibrium; active materials |
| 10/01/2002 | US6458825 Eukaryotic cells contain multiple proteolytic systems, including lysosomal proteases, calpains, atp-ubiquitin-proteasome dependent pathway, and an |
| 10/01/2002 | US6458822 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases |
| 10/01/2002 | US6458819 Thiazolium compounds and treatments of disorders associated with protein aging |
| 10/01/2002 | US6458813 2-cyclohexyloxy-5-(2-chlorophenylcarbonylamino)pyridine, for example; treating inflammation, pain, diabetes, cancer |
| 10/01/2002 | US6458812 Muscarinic antagonists |
| 10/01/2002 | US6458808 Pharmaceutical composition for the treatment of cognitive cerebrovascular disease |
| 10/01/2002 | US6458807 Methods for treating vascular dementia |
| 10/01/2002 | US6458791 Methods of treating muscle spasms using N-desmethylzopiclone |
| 10/01/2002 | US6458787 Novel pyrrolidine compounds that are potent and selective inhibitors of pde4, as well as methods of making the same, are disclosed. use of the compounds in the treatment of inflammatory diseases and other diseases involving elevated |
| 10/01/2002 | US6458776 Inflammatory bowel disease |
| 10/01/2002 | US6458775 NAALADase inhibitors useful as pharmaceutical compounds and compositions |
| 10/01/2002 | US6458770 Parenteral formulations comprising carbamazepine or its derivatives |
| 10/01/2002 | US6458760 Comprising administering to said patient a therapeutically effective amount of a compound which is a specific inhibitor of either cathepsin b or cathepsin l, but which is not as effective inhibitor of calpain |
| 10/01/2002 | US6458564 Amino acid sequence of the protease; for treating imbalance of desquamation |
| 10/01/2002 | US6458561 Human NIM1 kinase |
| 10/01/2002 | US6458541 Predicting likelihood of diagnosis by determining polymorphism in brain derived neurotrophic factor where presence of adenine at position 404 instead of guanine indicates lower likelihood |
| 10/01/2002 | US6458529 Assays for promoter operability in central nervous system cells |
| 10/01/2002 | US6458383 Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin |
| 10/01/2002 | US6458374 Methods and compositions for treating chronic disorders using optically pure (+)-bupropion |
| 10/01/2002 | US6458365 Method for treating headache |
| 10/01/2002 | US6458361 Soaking in water, heating beyond boiling point, stirring, filtering |
| 10/01/2002 | US6458360 Soluble complement regulatory molecules |
| 10/01/2002 | US6458357 Retro-inverso neurotrophic and analgesic peptides |
| 10/01/2002 | US6458338 Amino acid stabilized medicinal aerosol formulations |
| 10/01/2002 | CA2245857C 1,4-dihydropyridine compounds as bradykinin antagonists |
| 10/01/2002 | CA2241845C 4,5-dihydronaphth¬1,2-c|isoxazoles and derivatives thereof having cns activity |
| 10/01/2002 | CA2228370C Piperazino derivatives as neurokinin antagonists |
| 10/01/2002 | CA2210258C Substituted oxazolidine calpain and/or cathepsin b inhibitors |
| 10/01/2002 | CA2209735C Treatment of attention-deficit/hyperactivity disorder |
| 10/01/2002 | CA2209018C Sulfonamides and their use |
| 10/01/2002 | CA2203850C Novel n-phenyl-n-phenyliminonethylbenzamidines and their analogues as muscarinic receptor agonists |
| 10/01/2002 | CA2168113C Therapeutic peptide derivatives |
| 10/01/2002 | CA2089769C Heterocyclic compounds and their preparation and use |
| 10/01/2002 | CA2059708C Indole derivatives |
| 09/30/2002 | CA2379791A1 Novel triazine compounds useful as sorbitol dehydrogenase inhibitors |
| 09/27/2002 | CA2378876A1 Cyclohexylamine derivatives as subtype selective n-methyl-d-aspartate antagonists |
| 09/26/2002 | WO2002075317A2 Screening for drugs against disorders associated with schizophrenia |
| 09/26/2002 | WO2002074959A2 Human leucine-rich repeat containing protein expressed predominately in nervous system tissues, hlrrns1 |
| 09/26/2002 | WO2002074956A2 Dopaminergic neuronal survival-promoting factors and uses thereof |
| 09/26/2002 | WO2002074913A2 Nucleic acid-associated proteins |
| 09/26/2002 | WO2002074806A2 New interferon beta-like molecules |
| 09/26/2002 | WO2002074805A1 Soluble rage protein |
| 09/26/2002 | WO2002074784A2 Novel use of a peptide class of compound for treating non neuropathic inflammatory pain |
| 09/26/2002 | WO2002074780A1 Chemical compounds |
| 09/26/2002 | WO2002074773A1 Imidazo-pyrimidine derivatives as ligands for gaba receptors |
| 09/26/2002 | WO2002074772A1 Imidazo-pyrimidine derivatives as ligands for gaba receptors |
| 09/26/2002 | WO2002074771A1 Tricyclic heterocyclic compound, process for producing the same, and use |